Longevity CHI 2026 Conference

​​Longevity Global is launching our new Chicago chapter with an inaugural 2026 conference. We welcome scientists, engineers, entrepreneurs, and anyone interested in the science of longevity. Please join us in Cloud Gate Hub in 2 Prudential Plaza

Featuring our speakers:

​Alice Gilman, R3-bio.com

​Alice Gilman is a CEO for a stealth experimental stem cell based startup aimed at transforming the medical industry and delay aging.

​Alice is a visionary in regenerative medicine, longevity science, and advanced biotechnology, building the platforms that will define the next century of healthcare. Leading efforts to develop stem cell–based and genetically engineered systems capable of repairing, replacing, and enhancing human biology.

​

​Dr. Louise Hecker, PsiloHeal (Psilocybin and Longevity)

​

​Dr. Sofie Wei, PhD of X-Therma, Inc

​

​Dr. John Ramunas

​Dr. John Ramunas is a serial entrepreneur and neuroscientist dedicated to reversing human aging. He co-founded Rejuvenation Technologies to commercialize telomere extension technology he co-invented during his PhD in Neuroscience at Stanford University. His published research and patents span regenerative medicine, stem cells, RNA delivery, and microfluidics. Previously, he founded Pathways Development, a software company. His mission is to reverse aging—first to treat disease, and ultimately to restore youthful function to body and mind.

​

​Dr. Ashley Zehnder

​

​Dr. Glenn Markov

​Dr. Glenn Markov is Co-founder and COO of Rejuvenation Technologies, a company developing therapeutics to increase healthspan by extending telomeres. He holds a PhD in Genetics from Stanford University School of Medicine, where he researched nuclear reprogramming to pluripotency and the conversion of human fibroblasts to embryonic stem cells. His postdoctoral work at Stanford further advanced his expertise in regenerative medicine, genomics, and bioinformatics. Earlier, as an undergraduate researcher at Arizona State University and the Smithsonian Tropical Research Institute, he studied regeneration, evolutionary genomics, and cancer genetics. He earned dual BS degrees in Biology and Biochemistry from ASU, where he was named Outstanding Graduating Senior and received the Barry M. Goldwater Scholarship and an NSF Graduate Fellowship.

​

​Dr. Hazel Szeto

​
Schedule

Morning Session

​Longevity vs. Biotech Investing
Longevity Startup Showcase
Frontiers in Aging Biology

​Afternoon Session

​Clinical Longevity Medicine
The Emerging Longevity Care Economy